MELANOMA MARCH
RAISED OVER $675,000 FOR WORLD-FIRST CLINICAL TRIAL

Our Co-Medical Directors join MIA’s National Ambassador Peter Overton to discuss the ground-breaking PIP clinical trial and how it could transform cancer treatment globally.

Donate

STATE OF THE NATION

A Report into Melanoma –
a National Health Priority

WATCH STORY, READ THE REPORT

LATEST NEWS

MIA Co-Medical Director Prof Georgina Long AO named as world’s top melanoma expert

MIA Co-Medical Director Prof Georgina Long AO named as world’s top melanoma expert

Prof Long has been named No 1 Melanoma Expert in worldwide rankings just released by expertscape, based on articles published 2012-2022.

Australian researchers launch world-first tool to predict patient response to immunotherapy

Australian researchers launch world-first tool to predict patient response to immunotherapy

New clinical tool developed by Melanoma Institute Australia hailed a breakthrough in personalising treatment for all cancer patients.

Skin Cancer Tasmania merges with Melanoma Institute Australia

Skin Cancer Tasmania merges with Melanoma Institute Australia

Tasmanian skin cancer patients to benefit from increased prevention and awareness campaigns, and bolstered melanoma support services.

MIA’s MISSION
ZERO DEATHS FROM MELANOMA

MIA will achieve its mission through 3 pillars of action: Research, Clinical Care & Education.

MIA conducts its research under 5 themes; Prevention, Early Diagnosis & Treatment, Treatment of Metastatic Disease, Survivorship & Support and Health Economics.